Technical Analysis for OPGN - OpGen, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| MACD Bearish Signal Line Cross | Bearish | -4.10% | |
| 20 DMA Support | Bullish | -4.10% | |
| Wide Bands | Range Expansion | -4.10% | |
| NR7 | Range Contraction | -7.21% | |
| Narrow Range Bar | Range Contraction | -7.21% | |
| Wide Bands | Range Expansion | -7.21% | |
| Outside Day | Range Expansion | -11.14% | |
| Wide Bands | Range Expansion | -11.14% | |
| NR7 | Range Contraction | -9.87% | |
| NR7-2 | Range Contraction | -9.87% |
| Alert | Time |
|---|---|
| 20 DMA Support | about 3 hours ago |
| 60 Minute Opening Range Breakout | about 3 hours ago |
| 60 Minute Opening Range Breakdown | about 6 hours ago |
| Fell Below Previous Day's Low | about 6 hours ago |
| Down 5% | about 6 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 05/13/2024
OpGen, Inc. Description
OpGen, Inc. operates as an early commercial stage company using molecular testing and bioinformatics to assist healthcare providers to combat multi-drug-resistant bacterial infections. It offers Acuitas multi-drug-resistant organisms (MDRO) gene test, a molecular screening tool that detects 10 critical MDRO genes from 1 patient swab. The company also provides Acuitas CR Elite Test, which adds the ability to procure a standard microbiological culture result that provides additional information about the identified MDRO gene and its antibiotic susceptibility profile. In addition, it develops Acuitas Lighthouse MDRO bioinformatics product, which focuses on providing MDRO molecular information about an individual patient's resistance profile. OpGen, Inc. has a strategic collaboration with Hitachi High-Technologies Corporation to commercialize its genome mapping technology for mapping, assembly, and analysis of human DNA. The company was incorporated in 2001 and is headquartered in Gaithersburg, Maryland.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Healthcare Providers Antibiotics Genome Informatics Bacterial Infections Bioinformatics Veterinary Medicine Organisms Bacteria Antimicrobial Resistance Evolutionary Biology Multi Drug Resistant Bacterial Infections
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 3.84 |
| 52 Week Low | 0.165 |
| Average Volume | 2,091,898 |
| 200-Day Moving Average | 0.48 |
| 50-Day Moving Average | 0.53 |
| 20-Day Moving Average | 0.63 |
| 10-Day Moving Average | 0.69 |
| Average True Range | 0.08 |
| RSI (14) | 54.34 |
| ADX | 36.01 |
| +DI | 31.38 |
| -DI | 15.64 |
| Chandelier Exit (Long, 3 ATRs) | 0.74 |
| Chandelier Exit (Short, 3 ATRs) | 0.70 |
| Upper Bollinger Bands | 0.83 |
| Lower Bollinger Band | 0.44 |
| Percent B (%b) | 0.57 |
| BandWidth | 61.95 |
| MACD Line | 0.05 |
| MACD Signal Line | 0.06 |
| MACD Histogram | -0.0035 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.75 | ||||
| Resistance 3 (R3) | 0.75 | 0.71 | 0.73 | ||
| Resistance 2 (R2) | 0.71 | 0.69 | 0.71 | 0.73 | |
| Resistance 1 (R1) | 0.69 | 0.68 | 0.67 | 0.69 | 0.72 |
| Pivot Point | 0.65 | 0.65 | 0.64 | 0.65 | 0.65 |
| Support 1 (S1) | 0.63 | 0.63 | 0.61 | 0.63 | 0.59 |
| Support 2 (S2) | 0.59 | 0.62 | 0.59 | 0.59 | |
| Support 3 (S3) | 0.57 | 0.59 | 0.58 | ||
| Support 4 (S4) | 0.57 |
